These data indicated that the adenosine A2b receptor acted as an immunosuppressive target in an adenosine-enriched tumor microenvironment, because blocking this receptor with an antagonist repaired the suppressive effects caused by NECA. The gene discussed is ADORA2B; the disease is neoplasm.